Artiva Biotherapeutics, Inc. ARTV Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.42M-30.6% | $27.16M-32.9% | $25.97M-53.7% | $28.93M-16.2% | $30.86M-36.3% | ||
| $65.83M-51.4% | $81.31M— | $97.46M— | $113.9M— | $135.56M— | ||
| $88.74M-47.8% | $112.67M— | $129.52M— | $149.07M— | $170M— | ||
| $6.22M-11.9% | $6.62M— | $6.98M— | $6.89M— | $7.06M— | ||
| $105.96M-44.6% | $130.94M— | $148.86M— | $169.39M— | $191.26M— | ||
| $4.7M-9.5% | $4.45M+11.1% | $5.22M+49.0% | $5.59M+44.2% | $5.2M— | ||
| $11K-91.3% | $44K— | $75K— | $106K— | $126K— | ||
| $10.88M-10.8% | $13.09M— | $11.12M— | $10.77M— | $12.2M— | ||
| $18.11M-19.4% | $20.97M— | $19.64M— | $20.35M— | $22.48M— | ||
| —— | —— | —— | —— | —— | ||
| -$354.07M-32.6% | -$330.55M— | -$309.78M— | -$288.25M— | -$267M— | ||
| $87.85M-48.0% | $109.97M-41.1% | $129.22M-35.7% | $149.04M+178% | $168.78M+197% | ||
| $105.96M-44.6% | $130.94M— | $148.86M— | $169.39M— | $191.26M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Artiva Biotherapeutics, Inc.'s total assets?
- Artiva Biotherapeutics, Inc. (ARTV) holds $106.0M in total assets, down 44.6% year over year.
- How much debt does Artiva Biotherapeutics, Inc. have?
- Artiva Biotherapeutics, Inc. carries $10.3M in total debt against $87.8M of shareholders' equity, a debt-to-equity ratio of 0.12.
- How much cash does Artiva Biotherapeutics, Inc. have?
- Artiva Biotherapeutics, Inc. holds $21.4M in cash and equivalents.
- Can Artiva Biotherapeutics, Inc. cover its short-term obligations?
- Its current ratio is 8.16 — current assets exceed current liabilities.
- Where does Artiva Biotherapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.